Business
Moderna Tumbles After Nonpartisan Pledge, First Sell Rating – Bloomberg
Moderna Inc. fell 13% on Tuesday after regulators and top drugmakers promised the Covid-19 vaccine approval process would be immune from political pressure and the biotech company drew its first sell rating since going public in 2018.
Moderna Inc. fell 13% on Tuesday after regulators and top drugmakers promised the Covid-19 vaccine approval process would be immune from political pressure and the biotech company drew its first sell rating since going public in 2018.
Moderna’s vaccine is one of three leading candidates Wall Street expects may win an emergency use authorization near-term.. But pledges from the Food and Drug Administration and industry leaders have cast a pall over the prospects of a vaccine being approved befor…
-
Noosa News16 hours agoAllegedly armed man who sparked hours-long lockdown of Brisbane City Botanic Gardens in custody
-
Noosa News15 hours agoOnly person charged over Spear Creek murders admits he lied to police
-
Business19 hours agoGold price races towards US$4,200 on Tuesday
-
General15 hours agoSouth Sydney Rabbitohs player Tyrone Munro charged with domestic violence offences